Results 71 to 80 of about 8,517,970 (127)
Zuranolone and Brexanolone are Food and Drug Administration-approved novel agents for postpartum depression, yet real-world post-marketing safety data for the two drugs remain insufficient.
Liqun Chi +3 more
core +1 more source
American Journal of OtolaryngologyChronic rhinosinusitis with nasal polyps (CRSwNP) imposes a significant global disease burden. However, systematic comparisons of adverse drug reaction (ADR) profiles among these agents remain scarce, necessitating large-scale pharmacovigilance evaluation.Utilizing the WHO VigiAccess database, we analyzed 402,778 ADR reports for four biologics ...
Xiaobi, Fang, Tingfeng, Zhou, Fan, Ye
openaire +2 more sources
Objectives: To characterize the real-world safety profile of fezolinetant, a neurokinin-3 receptor antagonist approved for the treatment of menopausal vasomotor symptoms, using adverse event reports from the WHO ...
Xiaoling Gao +7 more
core +1 more source
Abstract Introduction: Sensorineural hearing loss (SNHL) is a common sensory disorder characterized by auditory nerve damage and cochlear dysfunction, often driven by oxidative stress, excitotoxicity, and neuroinflammation. Neuroprotective agents such as Cerebrolysin, Citicoline, Flunarizine, and Mecobalamin have demonstrated efficacy in ...
Shuainan Chen +4 more
openaire +1 more source
EndocrinesBackground/Objectives: Concerns regarding the psychiatric safety profile of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have increased since the 2023 European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) reviews.
Esteban Zavaleta-Monestel +5 more
doaj +1 more source
Background: The monitoring and analysis of adverse drug reactions (ADR’s) play a pivotal role in ensuring drug safety. In the context of a public health emergency of international concern (PHEIC), and the roll out of experimental COVID-19 vaccines, the ...
Theresa Lawrie, Andrew Bryant
core +1 more source
WHO Monographs on Medicinal Plants Commonly Used in the Newly Independent States (NIS)
, 2010 Since 1999, WHO has published four volumes of WHO monographs on selected medicinal plants, totaling 116 monographs. Despite the increasing use of herbal medicines, there is still a significant lack of research data in this field, so the WHO monographs ...
World Health Organization (WHO)
core +1 more source
Frontiers in PharmacologyObjectiveThe clinical risk of cognitive disorders linked to various drugs is not well-defined. This study aimed to identify medications with notable signals for drug-related cognitive disorders and evaluate whether their US Food and Drug Administration ...
Hao Wen, Yajie Dong, Ruiting Wang
doaj +1 more source
WHO launches CoViNet: a global network for coronaviruses [PDF]
WHO has launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities for early and accurate detection, monitoring and assessment of SARS-CoV-2, MERS-CoV and novel coronaviruses of public health ...
WHO Media Team
core
Background Tinnitus is a prevalent and often persistent symptom that imposes a substantial psychological and functional burden. Beyond disease-related mechanisms, accumulating real-world observations suggest that tinnitus may also ...
Zhuohao Li +4 more
core +1 more source